1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Clinical characteristics of patients
Characteristics Status of p53 P Value Mutated (%) (n = 116) Wild-Type (%) (n = 66) Age 40 yr and older 41 (55) 33 (45) .028 Younger than 40 yr 75 (69) 33 (31) Sex Male 70 (65) 37 (35) .469 Female 46 (61) 29 (39) History of seizures Yes 70 (62) 42 (38) .378 No 46 (66) 24 (34) Preoperative KPS ≥80 109 (65) 58 (35) .499 <80 7 (47) 8 (53) Pathology Oligodendroglioma 10 (36) 18 (64) .003 Astrocytoma 48 (76) 15 (24) Oligoastrocytoma 58 (64) 33 (36)
Note:—KPS indicates Karnofsky Performance Status Scale.